Sosei appoints Andrew Oakley as CFO
Mr Oakley, a Chartered Accountant with an MBA from London Business School, has had a wide and varied financial career and over the past 14 years has held CFO positions in several publicly listed biotechnology companies including Actelion Ltd, Novimmune SA, and most recently at Vectura Group plc, where he was also a member of the Board.
Commenting on the appointment, Peter Bains, CEO at Sosei, said: "Andrew brings a wealth of global corporate finance experience, expertise and leadership with a particularly strong focus in the biotechnology sector. I am delighted to welcome him to Sosei as our new CFO and look forward to working with Andrew in the coming years as we seek to build Sosei into a global presence"
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.